130 related articles for article (PubMed ID: 2651223)
1. Mechanism(s) of bioreductive activation. The example of diaziquone (AZQ).
Gutierrez PL
Free Radic Biol Med; 1989; 6(4):405-45. PubMed ID: 2651223
[TBL] [Abstract][Full Text] [Related]
2. Cellular activation of diaziquone [2,5-diaziridinyl-3,6-bis (carboethoxyamino)-1,4-benzoquinone] to its free radical species.
Gutierrez PL; Egorin MJ; Fox BM; Friedman R; Bachur NR
Biochem Pharmacol; 1985 May; 34(9):1449-55. PubMed ID: 3994758
[TBL] [Abstract][Full Text] [Related]
3. Free radicals in quinone containing antitumor agents. The nature of the diaziquone (3,6,-diaziridinyl-2,5-bis(carboethoxyamino)-1,4-benzoquinone) free radical.
Gutierrez PL; Bachur NR
Biochim Biophys Acta; 1983 Jul; 758(1):37-41. PubMed ID: 6305426
[TBL] [Abstract][Full Text] [Related]
4. Biochemical activation of AZQ [3,6-diaziridinyl-2,5-bis(carboethoxyamino)-1,4-benzoquinone] to its free radical species.
Gutierrez PL; Friedman RD; Bachur NR
Cancer Treat Rep; 1982 Feb; 66(2):339-42. PubMed ID: 6275990
[TBL] [Abstract][Full Text] [Related]
5. Free radicals in quinone-containing antitumor agents. Electrochemical reduction of diaziquone (2,5-diaziridine-3,6-bis(carboethoxyamino)-1,4 -benzoquinone) and two analogues.
Gutierrez PL; Fox BM; Mossoba MM; Bachur NR
Mol Pharmacol; 1984 Nov; 26(3):582-6. PubMed ID: 6092903
[TBL] [Abstract][Full Text] [Related]
6. The chemical reduction of diaziquone: products and free radical intermediates.
Gutierrez PL; Balachandran Nayar MS; Nardino R; Callery PS
Chem Biol Interact; 1987; 64(1-2):23-37. PubMed ID: 2826025
[TBL] [Abstract][Full Text] [Related]
7. Diaziquone, 2,5-diaziridinyl-3,6-biscarboethoxyamino-1,4-benzoquinone, plasma and cerebrospinal fluid kinetics.
Bachur NR; Collins JM; Kelley JA; Van Echo DA; Kaplan RS; Whitacre M
Clin Pharmacol Ther; 1982 May; 31(5):650-5. PubMed ID: 7075113
[TBL] [Abstract][Full Text] [Related]
8. Mechanism for the reductive activation of diaziquone.
Mossoba MM; Alizadeh M; Gutierrez PL
J Pharm Sci; 1985 Dec; 74(12):1249-54. PubMed ID: 4087189
[TBL] [Abstract][Full Text] [Related]
9. The reduction of anti-tumour diaziridinyl benzoquinones.
Butler J; Hoey BM; Lea JS
Biochim Biophys Acta; 1987 Aug; 925(2):144-9. PubMed ID: 3040109
[TBL] [Abstract][Full Text] [Related]
10. Reductive activation of diaziquone and possible involvement of free radicals and the hydroquinone dianion.
Gutierrez PL; Biswal S; Nardino R; Biswal N
Cancer Res; 1986 Nov; 46(11):5779-85. PubMed ID: 3019536
[TBL] [Abstract][Full Text] [Related]
11. Metabolism of diaziquone by NAD(P)H:(quinone acceptor) oxidoreductase (DT-diaphorase): role in diaziquone-induced DNA damage and cytotoxicity in human colon carcinoma cells.
Siegel D; Gibson NW; Preusch PC; Ross D
Cancer Res; 1990 Nov; 50(22):7293-300. PubMed ID: 2121335
[TBL] [Abstract][Full Text] [Related]
12. Effects of ascorbic acid on biologically obtained diaziquone free radicals.
Gutierrez PL; Egorin MJ; Davis TA; Bachur NR
Biochem Pharmacol; 1985 Jul; 34(13):2394-7. PubMed ID: 2990485
[No Abstract] [Full Text] [Related]
13. Reductive metabolism of diaziquone (AZQ) in the S9 fraction of MCF-7 cells. II. Enhancement of the alkylating activity of AZQ by NAD(P)H: quinone-acceptor oxidoreductase (DT-diaphorase).
Fisher GR; Donis J; Gutierrez PL
Biochem Pharmacol; 1992 Oct; 44(8):1625-35. PubMed ID: 1301071
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity relationships for DT-diaphorase reduction of hypoxic cell directed agents: indoloquinones and diaziridinyl benzoquinones.
Bailey SM; Suggett N; Walton MI; Workman P
Int J Radiat Oncol Biol Phys; 1992; 22(4):649-53. PubMed ID: 1544832
[TBL] [Abstract][Full Text] [Related]
15. The reductive metabolism of diaziquone (AZQ) in the S9 fraction of MCF-7 cells: free radical formation and NAD(P)H: quinone-acceptor oxidoreductase (DT-diaphorase) activity.
Fisher GR; Gutierrez PL
Free Radic Biol Med; 1991; 10(6):359-70. PubMed ID: 1654286
[TBL] [Abstract][Full Text] [Related]
16. Covalent binding studies on the 14C-labeled antitumor compound 2,5-bis(1-aziridinyl)-1,4-benzoquinone. Involvement of semiquinone radical in binding to DNA, and binding to proteins and bacterial macromolecules in situ.
Lusthof KJ; De Mol NJ; Janssen LH; Egberink RJ; Verboom W; Reinhoudt DN
Chem Biol Interact; 1990; 76(2):193-209. PubMed ID: 1699678
[TBL] [Abstract][Full Text] [Related]
17. Alkylation of DNA by the new anticancer agent 3,6-diaziridinyl-2,5-bis(carboethoxyamino)-1,4-benzoquinone (AZQ).
King CL; Wong SK; Loo TL
Eur J Cancer Clin Oncol; 1984 Feb; 20(2):261-4. PubMed ID: 6538490
[TBL] [Abstract][Full Text] [Related]
18. The influence of ascorbic acid on the free-radical metabolism of xenobiotics: the example of diaziquone.
Gutierrez PL
Drug Metab Rev; 1988; 19(3-4):319-43. PubMed ID: 3068033
[TBL] [Abstract][Full Text] [Related]
19. Electron spin resonance of electrochemically generated free radicals from diaziquone and its derivatives.
Gutierrez PL; Fox BM; Mossoba MM; Egorin MJ; Nakazawa H; Bachur NR
Biophys Chem; 1985 Jun; 22(1-2):115-23. PubMed ID: 2992620
[TBL] [Abstract][Full Text] [Related]
20. The influence of diaziquone free radicals on the in vitro activity of diaziquone.
Nguyen B; Biswal S; Gutierrez PL
Xenobiotica; 1988 May; 18(5):593-602. PubMed ID: 2840783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]